153 related articles for article (PubMed ID: 2156897)
1. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
Wilkins MR; Settle SL; Needleman P
J Clin Invest; 1990 Apr; 85(4):1274-9. PubMed ID: 2156897
[TBL] [Abstract][Full Text] [Related]
2. Depressor and natriuretic effects of M&B 22,948, a guanosine cyclic 3',5'-monophosphate-selective phosphodiesterase inhibitor.
McMahon EG; Palomo MA; Mehta P; Olins GM
J Pharmacol Exp Ther; 1989 Dec; 251(3):1000-5. PubMed ID: 2557409
[TBL] [Abstract][Full Text] [Related]
3. Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure.
Wilkins MR; Settle SL; Stockmann PT; Needleman P
Proc Natl Acad Sci U S A; 1990 Aug; 87(16):6465-9. PubMed ID: 2166956
[TBL] [Abstract][Full Text] [Related]
4. [Modulating effects of atrial natriuretic peptide on vascular permeability and blood pressure by inhibition of cyclic phosphodiesterase GMP in the rat].
Valentin JP; Humphreys MH
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1219-22. PubMed ID: 1336359
[TBL] [Abstract][Full Text] [Related]
5. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
Ni XP; Safai M; Gardner DG; Humphreys MH
Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
[TBL] [Abstract][Full Text] [Related]
6. Thiorphan-induced natriuresis in volume-expanded rats: roles of endogenous atrial natriuretic factor and kinins.
Bralet J; Mossiat C; Gros C; Schwartz JC
J Pharmacol Exp Ther; 1991 Sep; 258(3):807-11. PubMed ID: 1653839
[TBL] [Abstract][Full Text] [Related]
7. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibitor in conscious rats.
Koepke JP; Tyler LD; Trapani AJ; Bovy PR; Spear KL; Olins GM; Blaine EH
J Pharmacol Exp Ther; 1989 Apr; 249(1):172-6. PubMed ID: 2565386
[TBL] [Abstract][Full Text] [Related]
8. Modulation by low sodium intake of glomerular response to cicletanine and atrial natriuretic factor.
Kalinowski L; Szczepanska-Konkel M; Jankowski M; Angielski S
Br J Pharmacol; 1997 Jun; 121(4):635-42. PubMed ID: 9208128
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle.
Harris AL; Lemp BM; Bentley RG; Perrone MH; Hamel LT; Silver PJ
J Pharmacol Exp Ther; 1989 May; 249(2):394-400. PubMed ID: 2566675
[TBL] [Abstract][Full Text] [Related]
10. Blockade of the response to volume expansion by monoclonal antibodies against atrial natriuretic peptides.
Hirth C; Stasch JP; Kazda S; John A; Morich F; Neuser D; Wohlfeil S
Klin Wochenschr; 1987; 65 Suppl 8():87-91. PubMed ID: 2955164
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
Valentin JP; Ying WZ; Sechi LA; Ling KT; Qiu C; Couser WG; Humphreys MH
J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
[TBL] [Abstract][Full Text] [Related]
12. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
13. Effects of atrial natriuretic factor on renal function and cyclic GMP production.
Blaine EH; Seymour AA; Marsh EA; Napier MA
Fed Proc; 1986 Jun; 45(7):2122-7. PubMed ID: 2872085
[TBL] [Abstract][Full Text] [Related]
14. Subclasses of cyclic GMP-specific phosphodiesterase and their role in regulating the effects of atrial natriuretic factor.
Weishaar RE; Kobylarz-Singer DC; Keiser J; Haleen SJ; Major TC; Rapundalo S; Peterson JT; Panek R
Hypertension; 1990 May; 15(5):528-40. PubMed ID: 2158939
[TBL] [Abstract][Full Text] [Related]
15. Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor.
Silver PJ; Dundore RL; Bode DC; de Garavilla L; Buchholz RA; van Aller G; Hamel LT; Bacon E; Singh B; Lesher GY
J Pharmacol Exp Ther; 1994 Dec; 271(3):1143-9. PubMed ID: 7996419
[TBL] [Abstract][Full Text] [Related]
16. Negative functional effects of natriuretic peptides are attenuated in hypertrophic cardiac myocytes by reduced particulate guanylyl cyclase activity.
Meyer M; Zhang Q; Khurana K; Scholz PM; Weiss HR
J Cardiovasc Pharmacol; 2007 Feb; 49(2):100-5. PubMed ID: 17312451
[TBL] [Abstract][Full Text] [Related]
17. Acute and chronic haemodynamic and natriuretic effects of atriopeptin II in conscious rats.
Hofbauer KG; Criscione L; Sonnenburg C; Muir A; Mah SC
J Hypertens Suppl; 1986 Jun; 4(2):S41-7. PubMed ID: 2941543
[TBL] [Abstract][Full Text] [Related]
18. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
19. Brain natriuretic peptide (BNP) causes endothelium-independent relaxation and elevation of cyclic GMP in rat thoracic aorta.
Zhou HL; Fiscus RR
Neuropeptides; 1989 Oct; 14(3):161-9. PubMed ID: 2559355
[TBL] [Abstract][Full Text] [Related]
20. Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat.
Knight S; Snellen H; Humphreys M; Baylis C
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F655-9. PubMed ID: 17003222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
